Learn / ALKS
NASDAQ: ALKS
Alkermes plc. (ALKS) stock, explained like you're 5
Alkermes plc. trades on the Nasdaq under the ticker ALKS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6.8 billion dollars.
- Ticker
- ALKS
- Exchange
- Nasdaq
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Size
- Mid cap, about 6.8 billion dollars
Is Alkermes plc. a small, medium or large cap company?
No. Alkermes plc. is a mid cap stock, not a large cap. Its market cap, which is the total value of all its shares, is about 6.8 billion dollars.
Here is how you can tell. Multiply the share price by the number of shares to get the market cap, then compare it to the usual sizes. Micro cap is under 300 million dollars, small cap is 300 million to 2 billion, mid cap is 2 to 10 billion, large cap is 10 billion and up, and mega cap is over 200 billion. Market caps move every day with the share price, so treat the number as a recent snapshot.
How Alkermes plc. makes money
- Selling medicines, medical devices or healthcare services.
- Insurance premiums or hospital and clinic fees.
- Research and licensing deals.
What moves ALKS stock
- Results from clinical trials and approvals from regulators.
- Drug prices, insurance rules and government policy.
- Patents running out and new competing treatments.
In the news lately
- Alkermes plc (ALKS) stock price, news, quote and history (Yahoo Finance UK)
- ALKS Stock Surges 15% On Lilly Centessa Buyout Igniting Sleep Pipeline Hopes (Stocktwits)
- Alkermes stock reinstated Buy at Truist (ALKS:NASDAQ) (Seeking Alpha)
- Sleep Data Might Change The Case For Investing In Alkermes Stock (ALKS) (Simply Wall Street)
- Eight sleep research presentations are planned, including detailed results from a LUMRYZ trial. (Stock Titan)
Follow ALKS in your daily brief
Each trading day at 5 PM ET we post what happened to Alkermes plc. and why it matters, in simple words. Free.
Start my free briefKey terms to know before you follow ALKS
Questions about Alkermes plc. stock
What does Alkermes plc. do?
Alkermes plc. trades on the Nasdaq under the ticker ALKS. It is a mid cap company in the pharmaceutical preparations industry, part of the healthcare sector, with a market value of about 6.8 billion dollars.
What is the ticker symbol for Alkermes plc.?
Alkermes plc. trades under the ticker ALKS on the Nasdaq.
What is Alkermes plc.'s market cap?
Alkermes plc. is a mid cap stock with a market cap of about 6.8 billion dollars.
How does Alkermes plc. make money?
Selling medicines, medical devices or healthcare services. Insurance premiums or hospital and clinic fees. Research and licensing deals.
What moves ALKS stock?
Results from clinical trials and approvals from regulators. Drug prices, insurance rules and government policy. Patents running out and new competing treatments.
How can I follow ALKS stock every day?
Add ALKS to your watchlist on Metric Finance. We post a free brief every trading day at 5 PM ET that explains what happened to the stocks you follow, in simple words.
Similar stocks
Educational information, not financial advice. This guide explains the business in general terms and does not include live prices.